title: Late breaking trials of 2016 in structural heart disease and peripheral artery disease: Commentary covering ACC, EuroPCR, SCAI, TCT, VIVA, ESC, and AHA.
authors.affiliation: University of Colorado and Denver VA Medical Center, Denver, Colorado.
authors.forename: Ehrin J
authors.identifier: http://orcid.org/0000-0002-5682-8363
authors.initials: EJ
authors.lastname: Armstrong
authors.affiliation: Saint Luke's Mid America Heart Institute, Kansas City, Missouri.
authors.forename: Adnan K
authors.initials: AK
authors.lastname: Chhatriwalla
authors.affiliation: The Heart Hospital Baylor Plano, Plano, Texas.
authors.forename: Molly
authors.initials: M
authors.lastname: Szerlip
authors.affiliation: Division of Cardiology, Duke University Medical Center and the Duke Clinical Research Institute, Durham, North Carolina.
authors.forename: Rajesh V
authors.initials: RV
authors.lastname: Swaminathan
authors.affiliation: Ochsner Medical Center, New Orleans, Louisiana.
authors.forename: Rajan A G
authors.initials: RAG
authors.lastname: Patel
mesh_terms: D002986:Clinical Trials as Topic; D006331:Heart Diseases / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D058729:Peripheral Arterial Disease / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D012955:Societies, Medical; D016896:Treatment Outcome